[1] Hossain, M. A.; Ghannoum, M. A. Expert Opin. Invest. Drugs2000, 9, 1797. 
[2] Wexler, D.; Courtney, R.; Richards, W.; Banfield, C.; Lim, J.;Laughlin, M. Eur. J. Pharm. Sci. 2004, 21, 645.
[3] Stevens, D. J. Cancer. 1995, 32, 1.
[4] Odds, F. C. J. Antimicrob. Chemther. 1993, 31, 463. 
[5] Kauffman, C.; Carver, P. Drugs 1997, 53, 539. 
[6] Li, D.; Chen, B.-Y. Chin. J. Tuberc. Respir. Dis. 2009, 32, 235 (inChinese).(李冬, 陈佰义, 中华结核和呼吸杂志, 2009, 32, 235.)
[7] Pfaller, M. A.; Messer, S. A.; Hollis, R. J.; Jones, R. N.; Doern, G.V.; Brandt, M. E.; Hajjeh, R. A. Antimicrob. Agents Chemtherapy.1998, 42: 3242. 
[8] Law, D.; Moore, C. B.; Denning, D. W. Antimicrob. Agents Chemther.1997, 41, 2310.
[9] Fung-Tomc, J. C.; Huczko, E.; Minassian, B. Bonner, D. P. Antimicrob.Agents Chemther. 1998, 42, 313.
[10] Schell, W. A.; De Almeida, G. M. D.; Dodge, R. K.; Okonogi, K.J.; Perfect, J. R. Antimicrob. Agents Chemther. 1998, 42, 2630.
[11] Robert, A.; Fromtling, J.; Castaner, L. Drugs Fut. 1999, 24, 30. 
[12] Chai, X.-Y. M.S. Thesis, Second Military Medical University,Shanghai, 2009 (in Chinese).(柴晓云, 硕士论文, 第二军医大学, 上海, 2009.)
[13] Patrick, J. F.; Neil, J. G.; Rachel, F.; Alan, H.; Tom, B. Nucleic AcidsRes. 1996, 24, 3357. 
[14] National Committee for Clinical Laboratory Standards, ReferenceMethod for Broth Dilution Antifungal Susceptibility Testing ofYeasts Approved standard, Document M27-A2, National Committeefor Clinical Laboratory Standards, Wayne, PA, 2002. |